At the last check on Friday, OPKO Health Inc.’s (NASDAQ:OPK) stock was up $0.01, moving up 0.57 percent to $1.75. The average number of shares traded per day over the past five days has been 2,360,650 shares. 2 times new highs have been achieved over the past 5 days, with a -$0.0514 fall in that time frame. In the last twenty days, the average volume was 2,865,768, while in the previous 50 days, it was 4,185,341.
Since last month, OPK stock retreated -17.45%. Shares of the company fell to $1.7000 on 07/28/23, the lowest level in the past month. A 52-week high of $2.60 was reached on 07/05/23 after having rallying from a 52-week low of $1.00. Since the beginning of this year, OPK’s stock price has risen by 40.00% or $0.5086, and marked a new high 13 times. However, the stock has declined by -32.69% since its 52-week high.
OPK stock investors should be aware that OPKO Health Inc. (OPK) stock had its last reported insider trading activity 1 day ago on Aug 17. FROST PHILLIP MD ET AL, the CEO & Chairman of the company, purchased of 100,000 shares for $1.76 on Aug 17. It resulted in a $175,804 investment by the insider. FROST PHILLIP MD ET AL added 75,000 shares at an average price of $1.75 on Aug 14. The insider now owns 200,856,694 shares following the transaction. On Aug 09, CEO & Chairman FROST PHILLIP MD ET AL bought 100,000 shares at $1.82 apiece. The transaction was valued at $181,752.
Valuation Metrics
The stock’s beta is 1.76. Besides these, the trailing price-to-sales (P/S) ratio of 1.57, the price-to-book (PB) ratio of 0.86.
Financial Health
In the three months ended June 29, OPKO Health Inc.’s quick ratio stood at 1.60, while its current ratio was 1.90, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.15, and the total debt-to-equity ratio was 0.17. On the profitability front, the trailing twelve-month gross margin is 36.10% percent. In the year ended June 29, EBITDA margin amounted to -13.69%, whereas operating margins totaled -19.20%. Based on annual data, OPK earned $288.22 million in gross profit and brought in $1.0 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -8.90%. Return on equity (ROE) for the past 12 months was -13.30%.
According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. OPK’s revenue fell -16.75% to $237.58 million during the quarter, while net income inched up to $265.42 million. While analysts expected OPKO Health Inc. to report -$0.07 quarterly earnings, the actual figure was -$0.03 per share, beating the consensus estimate by 57.10%. During the quarter, the company generated $33.87 million in EBITDA. The liabilities of OPKO Health Inc. were 623.55 million at the end of its most recent quarter ended June 29, and its total debt was $295.67 million. The value of shareholders’ equity is $773.06 million.
Technical Picture
This quick technical analysis looks at OPKO Health Inc.’s (OPK) price momentum. With a historical volatility rate of 50.74%, the RSI 9-day stood at 42.85% on 17 August.
With respect to its five-day moving average, the current OPKO Health Inc. price is down by -2.84% percent or -$0.0514. At present, OPK shares trade -14.21% below its 20-day simple moving average and +33.23% percent above its 100-day simple moving average. However, the stock is currently trading approximately +11.30% above its SMA50 and -7.44% below its SMA200.
Stochastic coefficient K was 9.21% and Stochastic coefficient D was 14.31%, while ATR was 0.1101. Given the Stochastic reading of 6.43% for the 14-day period, the RSI (14) reading has been calculated as 44.62%. As of today, the MACD Oscillator reading stands at -0.0303, while the 14-day reading stands at -0.0499.
Analyst Ratings
Barrington Research upgraded its rating on OPKO Health Inc. (NASDAQ: OPK) to an Outperform in a note to investors on June 29, 2023. The analysts firm previously had a Mkt perform rating on the stock.OPKO Health Inc. (OPK) has been rated Buy by analysts. According to 0 brokerage firms, OPK is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate OPKO Health Inc. stock as buy, with 6 recommending it as overweight.
With a median target price of $4.00, the current consensus forecast for the stock is $2.00 – $8.50. Based on these forecasts, analysts predict OPKO Health Inc. (OPK) will achieve an average price target of $4.48.
